Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that it enclosed details of issue of duplicate share certificate against loss of share certificate on April 12, 2023 received from Registrar and Transfer Agent, Bigshare Services.
The above information is a part of company’s filings submitted to BSE.